The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback